"An Oncology Innovation Conference Where Health IT And Biotech Intersect" - Stephanie Baum
MedCity Converge is a conference on innovation in cancer treatment and precision medicine. The Philadelphia event brings together thought leaders across venture capital, providers, pharma, patient advocates, health IT, and the startup community. Joshua Brody, MD, assistant professor of medicine, hematology and medical oncology and director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, will be the opening keynote speaker offering his perspective on the impact of immunotherapy and the hype that surrounds this innovative approach to cancer treatment.
-Joshua Brody, MD, Assistant Professor, Medicine, Hematology and Medical Oncology, Director, Lymphoma Immunotherapy Program, Icahn School of Medicine at Mount Sinai